CD46 is a significant complement receptor protein that promotes human cytotoxic CD8+ T cell activity and relates with autoimmune diseases (Liszewski and Atkinson, 2015; Arbore et al., 2018; Stein et al., 2019). Here, CD8A is linked to autoimmune disease.